Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Müller

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 5, 2016
BBB penetration-targeting physicochemical lead selection: Ecdysteroids as chemo-sensitizers against CNS tumorsJudit Müller, Ana Martins, József Csábi, et al.
Frontiers in Pediatrics|October 3, 2022
Potential role of <i>MAP2K1</i> mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature reviewAlex Jenei, Gábor Bedics, Dániel J Erdélyi, et al.
Journal of the American College of Nutrition|November 4, 2008
Improper supplementation habits of folic acid intake by Hungarian pregnant women: improper recommendationsMárta Bognár, Andrea Ponyi, Péter Hauser, et al.
Cancer Genetics and Cytogenetics|April 18, 2003
Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemiaIrén Haltrich, Judit Müller, Judit Szabó, et al.
Orvosi Hetilap|February 26, 2013
[Examination of late pulmonary toxicity in children treated for malignancies]Zsófia Jordán, Zsófia Tokodi, Agnes Németh, et al.
Children (Basel, Switzerland)|July 29, 2023
Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic DiseasesJudit Müller, Petra Egyed, Daniel Erdelyi, et al.
Orvosi Hetilap|November 23, 2006
[Alternative therapy in childhood cancer]Hajnalka Szirmai, Eniko Földesi, Csilla Zsámbor, et al.
Journal of Pediatric Hematology/Oncology|March 8, 2005
Incidence and survival of central nervous system involvement in childhood malignancies: Hungarian experiencePéter Hauser, Zsuzsanna Jakab, Orsolya Láng, et al.
Pathology Oncology Research : POR|April 22, 2022
Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric LeukemiaBálint Egyed, Anna Horváth, Ágnes F Semsei, et al.
European Journal of Pediatrics|December 13, 2006
Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?Gábor T Kovács, Hajna Erlaky, Kornélia Tóth, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 5, 2016
BBB penetration-targeting physicochemical lead selection: Ecdysteroids as chemo-sensitizers against CNS tumorsJudit Müller, Ana Martins, József Csábi, et al.
Frontiers in Pediatrics|October 3, 2022
Potential role of <i>MAP2K1</i> mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature reviewAlex Jenei, Gábor Bedics, Dániel J Erdélyi, et al.
Journal of the American College of Nutrition|November 4, 2008
Improper supplementation habits of folic acid intake by Hungarian pregnant women: improper recommendationsMárta Bognár, Andrea Ponyi, Péter Hauser, et al.
Cancer Genetics and Cytogenetics|April 18, 2003
Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemiaIrén Haltrich, Judit Müller, Judit Szabó, et al.
Orvosi Hetilap|February 26, 2013
[Examination of late pulmonary toxicity in children treated for malignancies]Zsófia Jordán, Zsófia Tokodi, Agnes Németh, et al.
Children (Basel, Switzerland)|July 29, 2023
Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic DiseasesJudit Müller, Petra Egyed, Daniel Erdelyi, et al.
Orvosi Hetilap|November 23, 2006
[Alternative therapy in childhood cancer]Hajnalka Szirmai, Eniko Földesi, Csilla Zsámbor, et al.
Journal of Pediatric Hematology/Oncology|March 8, 2005
Incidence and survival of central nervous system involvement in childhood malignancies: Hungarian experiencePéter Hauser, Zsuzsanna Jakab, Orsolya Láng, et al.
Pathology Oncology Research : POR|April 22, 2022
Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric LeukemiaBálint Egyed, Anna Horváth, Ágnes F Semsei, et al.
European Journal of Pediatrics|December 13, 2006
Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?Gábor T Kovács, Hajna Erlaky, Kornélia Tóth, et al.
Pageof 7